Home | Welcome to Contract Pharma   
Last Updated Friday, October 24 2014
Print

Allergan Names CFO



Published August 18, 2014
Related Searches: Development
Jim Hindman has been named executive vice president of finance and business development, and chief financial officer at Allergan, Inc. Mr. Hindman succeeds Jeff Edwards, who after 21 years has decided to step down from the position, but will serve as a non-executive officer to facilitate the transition.
 
Mr. Hindman joined the company in 1984 and has served as senior vice president, Treasury, Risk and Investor Relations since 2002. Prior to that, he served in a variety of finance positions, including senior vice president, finance and controller, assistant corporate controller and vice president, Financial Planning and Analysis. Mr. Hindman also serves as president of The Allergan Foundation.  
 
“For more than two decades, Jeff Edwards has fully committed his considerable talents to serving Allergan and we have been exceptionally privileged to have him as a colleague,” said David E.I. Pyott, Allergan’s chairman and chief executive officer.
 
Mr. Pyott added, “We are pleased to name Jim Hindman as Allergan’s chief financial officer. Jim has been an instrumental member of our organization for many years, and particularly during the past few months, has played an important leadership role. We believe that Jim is ideally suited to assume the position of chief financial officer and we are confident that his long tenure and experience in our finance organization, together with his strong record as a leader in the Company, will be invaluable as he assumes his new role.”


blog comments powered by Disqus
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On